Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Current Eye Research|December 22, 2020
The Role of Plasma Calprotectin in Non-infectious UveitisElia Valls Pascual, Lucía Martínez-Costa Pérez, Antonio Hernández Pons, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 12, 2019
Functional remediation improves bipolar disorder functioning with no effects on brain-derived neurotrophic factor levelsCaterina Del Mar Bonnin, Elia Valls, Adriane R Rosa, et al.The International Journal of Neuropsychopharmacology|May 13, 2017
Cognitive Impairment in Bipolar Disorder: Treatment and Prevention StrategiesBrisa Solé, Esther Jiménez, Carla Torrent, et al.BMC Musculoskeletal Disorders|April 22, 2023
Relationship between trabecular bone score, bone mineral density and vertebral fractures in patients with axial spondyloarthritisElia Valls-Pascual, Ana Victoria Orenes-Vera, Ana Sendra-García, et al.Clinical and Experimental Rheumatology|April 22, 2021
Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypesBelén Atienza-Mateo, Emma Beltrán, Marisa Hernández-Garfella, et al.Clinical and Experimental Rheumatology|April 8, 2016
The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label studyMontserrat Santos-Gómez, Vanesa Calvo-Río, Ricardo Blanco, et al.Ophthalmology|January 19, 2020
Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study GroupVictor Llorenç, Miguel Cordero-Coma, Ana Blanco-Esteban, et al.Rheumatology International|November 6, 2016
Development of an activity disease score in patients with uveitis (UVEDAI)Esperanza Pato, Mª Auxiliadora Martin-Martinez, Adela Castelló, et al.Schizophrenia Bulletin|May 27, 2015
A Multisite, Randomized Controlled Clinical Trial of Computerized Cognitive Remediation Therapy for SchizophreniaJesús J Gomar, Elia Valls, Joaquim Radua, et al.Rheumatology (Oxford, England)|February 23, 2018
Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective studyBelén Atienza-Mateo, Vanesa Calvo-Río, Emma Beltrán, et al.Pageof 3